A Randomized Clinical Trial to Study the Effects of MK0752 Versus Placebo on Biomarkers in Healthy Young Adult Male Subjects.

Trial Profile

A Randomized Clinical Trial to Study the Effects of MK0752 Versus Placebo on Biomarkers in Healthy Young Adult Male Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 17 Aug 2015

At a glance

  • Drugs MK 0752 (Primary)
  • Indications Alzheimer's disease; Cancer
  • Focus Biomarker; Pharmacodynamics
  • Sponsors Merck & Co
  • Most Recent Events

    • 18 Apr 2010 Results have been reported in an abstract presented at the American Association for Cancer Research meetiing in April 2010 (AACR 2010)
    • 23 Jul 2009 Actual end date changed from Apr 2009 to May 2009 as reported by ClinicalTrials.gov.
    • 18 Apr 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top